Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arctiva is a dermatology-focused biotechnology company that develops and markets medicated skincare products for chronic conditions. The company's core innovation is the HYDROSURF technology, a proprietary blend of fermented glycolipids designed to enhance the delivery and efficacy of active ingredients. Arctiva's product line includes steroid-free treatments for psoriasis, eczema, and seborrheic dermatitis, offering medical-grade relief through over-the-counter formulations. By combining advanced biosurfactants with proven active ingredients, the company aims to restore the skin's natural barrier and provide long-term relief for sensitive skin. The company operates as a brand under Disruption Labs, leveraging specialized fermentation processes to create sustainable and effective topical solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arctiva Wellness.